Skip to main content

Atara Biotherapeutics, Inc.

ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001604464

In the last 90 days, Atara Biotherapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 36 institutions reported holding it in 13F filings for Q2 2026, worth $51.3M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Atara Biotherapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
139
0 vs. Q3 2021
Shares held
95.2M
+5.47M (+6.1%) vs. Q3 2021
Total value
$1.50B
−$105.6M (−6.6%) vs. Q3 2021
New holders
15
52 more added
Sold out
15
47 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ATRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 139 institutions
Q1 2021: 151 institutionsQ2 2021: 145 institutionsQ3 2021: 140 institutionsQ4 2021: 139 institutionsQ1 2022: 145 institutionsQ2 2022: 134 institutionsQ3 2022: 155 institutionsQ4 2022: 139 institutionsQ1 2023: 125 institutionsQ2 2023: 118 institutionsQ3 2023: 109 institutionsQ4 2023: 91 institutionsQ1 2024: 82 institutionsQ2 2024: 48 institutionsQ3 2024: 35 institutionsQ4 2024: 43 institutionsQ1 2025: 37 institutionsQ2 2025: 32 institutionsQ3 2025: 37 institutionsQ4 2025: 41 institutionsQ1 2026: 33 institutionsQ2 2026: 36 institutions
Value heldQ4 2021: $1.50B
Q1 2021: $1.24BQ2 2021: $1.34BQ3 2021: $1.61BQ4 2021: $1.50BQ1 2022: $909.5MQ2 2022: $777.4MQ3 2022: $376.2MQ4 2022: $319.3MQ1 2023: $297.8MQ2 2023: $145.8MQ3 2023: $130.5MQ4 2023: $33.2MQ1 2024: $57.8MQ2 2024: $24.1MQ3 2024: $19.6MQ4 2024: $31.5MQ1 2025: $12.4MQ2 2025: $13.9MQ3 2025: $27.0MQ4 2025: $37.1MQ1 2026: $12.1MQ2 2026: $51.3M
Institutions holding ATRA and their total value by quarter
QuarterHoldersValue
Q2 202636$51.3M
Q1 202633$12.1M
Q4 202541$37.1M
Q3 202537$27.0M
Q2 202532$13.9M
Q1 202537$12.4M
Q4 202443$31.5M
Q3 202435$19.6M
Q2 202448$24.1M
Q1 202482$57.8M
Q4 202391$33.2M
Q3 2023109$130.5M
Q2 2023118$145.8M
Q1 2023125$297.8M
Q4 2022139$319.3M
Q3 2022155$376.2M
Q2 2022134$777.4M
Q1 2022145$909.5M
Q4 2021139$1.50B
Q3 2021140$1.61B
Q2 2021145$1.34B
Q1 2021151$1.24B

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Atara Biotherapeutics, Inc.; share changes are against Q3 2021.

Institutions holding ATRA in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
UBS Group AG245,594$3.87M0.00%+110,274+81.5%Added
Staley Capital Advisers Inc250,000$3.94M0.19%00.0%Unchanged
Rafferty Asset Management, LLC252,923$3.99M0.02%+130,206+106.1%Added
Alberta Investment Management Corp281,130$4.43M0.03%−317,200−53.0%Reduced
One Fin Capital Management LP303,000$4.78M1.99%+303,000New
Bank of New York Mellon Corp309,307$4.88M0.00%+6,276+2.1%Added
Pinnacle Associates Ltd449,704$7.09M0.12%−2,123−0.5%Reduced
M28 Capital Management LP456,865$7.20M5.62%+456,865New
Pacific Heights Asset Management LLC525,000$8.27M0.70%00.0%Unchanged
Bridger Management, LLC616,488$9.72M1.26%−310,100−33.5%Reduced
Charles Schwab Investment Management Inc616,461$9.72M0.00%+31,932+5.5%Added
Deep Track Capital, LP750,000$11.8M0.87%+750,000New
Natixis762,700$12.0M0.04%+635,000+497.3%Added
Northern Trust Corp860,257$13.6M0.00%+17,008+2.0%Added
D. E. Shaw & Co., Inc.919,401$14.5M0.02%+87,494+10.5%Added
Norges Bank975,858$15.4M0.00%+225,244+30.0%Added
Antipodean Advisors LLC1,000,000$15.8M6.47%−50,000−4.8%Reduced
Citigroup Inc1,013,279$16.0M0.01%+742,430+274.1%Added
Eminence Capital, LP1,141,457$18.0M0.23%+1,141,457New
Nuveen Asset Management, LLC1,160,460$18.3M0.01%+99,721+9.4%Added
Ameriprise Financial Inc1,176,264$18.5M0.01%+424,291+56.4%Added
Dimensional Fund Advisors LP1,224,510$19.3M0.01%+313,582+34.4%Added
Artal Group S.A.1,500,000$23.6M0.69%00.0%Unchanged
Geode Capital Management, LLC1,620,465$25.5M0.00%+147,643+10.0%Added
683 Capital Management, LLC1,781,234$28.1M1.34%00.0%Unchanged
KPCB XV Associates, LLC1,876,650$29.6M23.33%00.0%Unchanged
Assenagon Asset Management S.A.1,948,815$30.7M0.11%+439,087+29.1%Added
Wasatch Advisors Inc2,025,516$31.9M0.13%−881,995−30.3%Reduced
Morgan Stanley2,543,048$40.1M0.00%−266,712−9.5%Reduced
Goldman Sachs Group Inc2,564,527$40.4M0.01%−309,750−10.8%Reduced
State Street Corp4,324,199$68.1M0.00%+543,302+14.4%Added
Point72 Asset Management, L.P.4,613,700$72.7M0.32%+2,295,400+99.0%Added
FMR LLC5,613,242$88.5M0.01%+1,130,696+25.2%Added
Redmile Group, LLC6,437,777$101.5M2.31%−28,500−0.4%Reduced
Vanguard Group Inc7,075,521$111.5M0.00%+274,938+4.0%Added
JPMorgan Chase & Co7,417,122$116.9M0.01%−598,695−7.5%Reduced
BlackRock Inc.7,816,552$123.2M0.00%+164,961+2.2%Added
Maverick Capital LtdSuperinvestorMaverick Capital7,855,824$123.8M1.50%00.0%Unchanged
Baupost Group LLCSuperinvestorBaupost Group8,477,488$133.6M1.32%00.0%Unchanged
Lion Point Capital, LP0$00.00%−350,465−100.0%Sold out
Renaissance Technologies LLC0$00.00%−281,679−100.0%Sold out
Two Sigma Investments, LP0$00.00%−246,136−100.0%Sold out
Los Angeles Capital Management LLC0$00.00%−24,491−100.0%Sold out
Ergoteles LLC0$00.00%−20,987−100.0%Sold out
Vontobel Holding Ltd.0$00.00%−20,000−100.0%Sold out
Group One Trading, L.P.0$00.00%−13,838−100.0%Sold out
Susquehanna Fundamental Investments, LLC0$00.00%−10,907−100.0%Sold out
LPL Financial LLC0$00.00%−10,120−100.0%Sold out
Nisa Investment Advisors, LLC0$00.00%−4,620−100.0%Sold out
Pacitti Group Inc.0$00.00%−2,000−100.0%Sold out
Penserra Capital Management LLC0$00.00%−1,940−100.0%Sold out
IFP Advisors, Inc0$00.00%−750−100.0%Sold out
Cutler Group LP0$00.00%−300−100.0%Sold out
Gerber Kawasaki Wealth & Investment Management0$00.00%−210−100.0%Sold out
Berman Capital Advisors, LLC––––Not filed